There are 15,355 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
1 June 2022
Chamber_Minutes_20220601
Access to Cannabis-based Products for Medicinal Use: The Parliament debated S6M-03233 in the name of Collette Stevenson—That the Parliament welcomes the Home Office’s rescheduling of certain cannabis-based products for medicinal use (CBPMs) in 2018; notes the reported improvement in some children with treatment resistant epilepsy who take CBPMs, such as Cole Thomson, from East Kilbride, who it understands receives Bedrolite on private prescription; acknowledges the reported financial pressure that these prescriptions can place on families; further acknowledges the reported hesitancy of NHS consultants to prescribe unlicensed CBPMs due to the lack of robust evidence; notes the view that the rescheduling does not go far enough in assisting some patients, and the calls for a change in rules to allow GPs, who consider it appropriate, to prescribe unlicensed CBPMs where a non- NHS consultant has initiated that course of treatment; understands that the British Paediatric Neurology Association published its updated Guidance on the use of cannabis-based products for medicinal use in children and young people with epilepsy in October 2021, which, it considers, outlines concerns around the lack of randomised control trials demonstrating a product’s safety, quality and efficacy; acknowledges the Scottish Government’s reported commitment to collaborate with NHS England and the National Institute for Health Research to support research trials into medicinal cannabis in order to give NHS consultants the assurances that they need to consider prescribing CBPMs on the NHS; understands that, once a medicinal product has undergone clinical trials, it could be considered by the Medicines and Healthcare products Regulatory Agency for licensing and that this could lead to further consideration by organisations such as the National Institute for Health and Care Excellence, the Scottish Medicines Consortium and NHS Scotland; notes the calls for industry to run observational and clinical trials; believes that an increased evidence base offers the best opportunities for expansion of the range of CBPMs available from the NHS; welcomes the reported plans by Target Healthcare, which operates in East Kilbride, to produce CBPMs in Scotland, and notes the calls on the Scottish and UK governments to work together to find solutions on these issues.
Last updated:
19 November 2025
PE1976_M
PE1976/M: Backdate council tax discounts for dementia to the date of GP certification Petitioner written submission, 12 November 2025 I warmly welcome the written submission by the Cabinet Secretary for Finance and Local Government, Shona Robison MSP, in particular paragraphs 3 and 4:- "The Scottish Government appreciates the concerns raised by the Committ...
Last updated:
20 February 2025
1 February 2024 SPCB Minute
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 1 February 2024 at 9.00am Present: • Alison Johnstone MSP (chair) • Claire Baker MSP • Jackson Carlaw MSP • Maggie Chapman MSP • Christine Grahame MSP In attendance: • Michelle Hegarty • Judith Morrison • Kenny Htet-Khin • Huw Williams • Eric MacLeod • Mark Brough • Lisa C...
Last updated:
20 February 2025
31 January 2024 SPCB Minute
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Wednesday 31 January 2024 at 3.00pm Present: • Alison Johnstone MSP (chair) • Claire Baker MSP • Jackson Carlaw MSP • Maggie Chapman MSP • Christine Grahame MSP In attendance: • Michelle Hegarty • Judith Morrison • Kenny Htet-Khin • Huw Williams • Eric MacLeod • Mark Brough • Lisa ...
Last updated:
20 May 2022
SPCB Minute 5 May 2022
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 5 May 2022 at 16.30.
Committee reports
Date published:
20 April 2017
Stage 1 Report on the Limitation (Childhood Abuse) (Scotland) Bill - Annex C - Informal testimonies
Annex C - Informal testimonies
Notes of informal testimonies from survivors
Note of meeting with survivor R
Note of meeting with survivors T and M
Questions and Answers
Date answered:
16 August 2021
S6W-01325
Details of the grants awarded by Scottish Government through the Forestry Grant Scheme is shown in the following table: Year Management of native woodlands Expansion of native woodlands 2015 N/A £1.2 M 2016 £1.3 M 3.45 M 2017 £2.35 M £5.9 M 2018 £1.08 M £12.4 M 2019 £1.15 M £11.1 M 2020 £1.63 M £14.07 M In 2015, no grants were awarded for the management of native woodlands as this grant option was launched in 2015.
Last updated:
7 March 2023
BB20210121
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
18 September 2024
BusinessPlanningDaySummaryNote_29Aug24
The DDU aims to revolutionise drug discovery by making the treatment of diseases previously thought to be ‘undruggable’ a reality. It was noted that medicinal chemists “do the reflecting and redesigning that eventually spits out medicine”.
SPICe briefings
Date published:
16 January 2020
Medicines in Scotland - Consumption
Retrieved from <a href="https://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Publications/2019-07-23/2019-07-23-Dispenser-Payments-and-Prescription-Cost-Analysis-Report.pdf" target="_blank">https://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Publications/2019-07-23/2019-07-23-Disp...
